from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3718c/-

LFCtreatmentdescriptionclass of inhibitor

-1.094

Amikacinug/mL Amikacintranslation

-0.326

Cap5-10ug/mL Capreomycintranslation

-0.740

Rox10-50 ug/mL Roxithromycintranslation

0.486

SM2-5 ug/mL Streptomycintranslation

-0.141

Tet5-10 ug/mL Tetracyclinetranslation

0.854

Rif0.2-5ug/mL Rifampicintranscription

-0.578

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.205

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.738

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.073

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.754

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.094

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.175

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.155

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.077

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.048

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.268

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.320

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.512

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.362

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.341

KCN5-20 ug/mL Potassium cyaniderespiration

0.279

NaN30.2-2 mM Sodium aziderespiration

-0.179

Nigericin50 uM Nigericinrespiration

-0.960

TRC10-150 ug/mL Triclosanrespiration

-1.470

TRZ10-25 ug/mL Thioridazinerespiration

-0.758

Valinomycin0.5-10 uM Valinomycinrespiration

-0.167

ZnSO42 mM ZnSO4respiration

0.999

menadione6-10 ug/mL Menadionerespiration

0.351

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.269

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.919

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.624

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.259

NRP_1Non-replicating persistence stage 1dosRassociated

0.143

Amp0.2mg/mL AmpicillincellWall

-0.070

Cephalexin20-100 ug/mL CephalexincellWall

0.366

Cerulenin0.32-5 ug/mL CerulenincellWall

0.670

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.413

EMB10-20 ug/mL EthambutolcellWall

-0.073

Eta12-40 ug/mL EthionamidecellWall

-0.348

INH0.2-0.4 ug/mL IsoniazidcellWall

0.159

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.302

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.410

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.190

BZA0.12 mg/mL BenzamidearomaticAmides

0.046

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.459

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.693

H2O24 mM hydrogen peroxideDNAdamaging

0.041

Levo10 ug/mL LevofloxacinDNAdamaging

0.719

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.328

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.683

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.542

UVUV-irradiationDNAdamaging

-0.510

ARP41-4 ug/mL Antitubercular compound ARP4?

0.140

Antimycin12.5-50 ug/mL Antimycin A?

0.264

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.168

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.447

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.148

PA8240.2-2 ug/mL PA-824?

-0.702

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.055

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.256

Verapamil50 uM Verapamil?

0.313

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.115

methoxatin10-20 ug/mL Methoxatin?